Triage body temperature and its influence on patients with acute myocardial infarction.
Body temperature
Emergency department
In-hospital cardiac arrest
Myocardial infarction
Triage
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
04 08 2023
04 08 2023
Historique:
received:
12
09
2022
accepted:
28
06
2023
medline:
7
8
2023
pubmed:
5
8
2023
entrez:
4
8
2023
Statut:
epublish
Résumé
Fever can occur after acute myocardial infarction (MI). The influence of body temperature (BT) after hospital arrival on patients with acute MI has rarely been investigated. Patients who were diagnosed with acute MI in the emergency department (ED) of a tertiary teaching hospital between 1 January 2020 and 31 December 2020 were enrolled. Based on the tympanic temperature obtained at the ED triage, patients were categorized into normothermic (35.5°C-37.5°C), hypothermic (< 35.5°C), or hyperthermic (> 37.5°C) groups. The primary outcome was in-hospital cardiac arrest (IHCA), while the secondary outcomes were adverse events. Statistical significance was set at p < 0.05. There were 440 enrollees; significant differences were found among the normothermic (n = 369, 83.9%), hypothermic (n = 27, 6.1%), and hyperthermic (n = 44, 10.0%) groups in the triage respiratory rate (median [IQR]) (20.0 [4.0] cycles/min versus 20.0 [4.0] versus 20.0 [7.5], p = 0.009), triage heart rate (88.0 [29.0] beats/min versus 82.0 [28.0] versus 102.5 [30.5], p < 0.001), presence of ST-elevation MI (42.0% versus 66.7% versus 31.8%, p = 0.014), need for cardiac catheterization (87.3% versus 85.2% versus 72.7%, p = 0.034), initial troponin T level (165.9 [565.2] ng/L versus 49.1 [202.0] versus 318.8 [2002.0], p = 0.002), peak troponin T level (343.8 [1405.9] ng/L versus 218.7 [2318.2] versus 832.0 [2640.8], p = 0.003), length of ICU stay (2.0 [3.0] days versus 3.0 [8.0] versus 3.0 [9.5], p = 0.006), length of hospital stay (4.0 [4.5] days versus 6.0 [15.0] versus 10.5 [10.8], p < 0.001), and infection during hospitalization (19.8% versus 29.6% versus 63.6%, p < 0.001) but not in IHCA (7.6% versus 14.8% versus 11.4%, p = 0.323) or any adverse events (50.9% versus 48.1% versus 63.6%, p = 0.258). Multivariable analysis showed no significant association of triage BT with IHCA or any major complication. Triage BT did not show a significant association with IHCA or adverse events in patients with acute MI. However, triage BT could be associated with different clinical presentations and should warrant further investigation.
Sections du résumé
BACKGROUND
Fever can occur after acute myocardial infarction (MI). The influence of body temperature (BT) after hospital arrival on patients with acute MI has rarely been investigated.
METHODS
Patients who were diagnosed with acute MI in the emergency department (ED) of a tertiary teaching hospital between 1 January 2020 and 31 December 2020 were enrolled. Based on the tympanic temperature obtained at the ED triage, patients were categorized into normothermic (35.5°C-37.5°C), hypothermic (< 35.5°C), or hyperthermic (> 37.5°C) groups. The primary outcome was in-hospital cardiac arrest (IHCA), while the secondary outcomes were adverse events. Statistical significance was set at p < 0.05.
RESULTS
There were 440 enrollees; significant differences were found among the normothermic (n = 369, 83.9%), hypothermic (n = 27, 6.1%), and hyperthermic (n = 44, 10.0%) groups in the triage respiratory rate (median [IQR]) (20.0 [4.0] cycles/min versus 20.0 [4.0] versus 20.0 [7.5], p = 0.009), triage heart rate (88.0 [29.0] beats/min versus 82.0 [28.0] versus 102.5 [30.5], p < 0.001), presence of ST-elevation MI (42.0% versus 66.7% versus 31.8%, p = 0.014), need for cardiac catheterization (87.3% versus 85.2% versus 72.7%, p = 0.034), initial troponin T level (165.9 [565.2] ng/L versus 49.1 [202.0] versus 318.8 [2002.0], p = 0.002), peak troponin T level (343.8 [1405.9] ng/L versus 218.7 [2318.2] versus 832.0 [2640.8], p = 0.003), length of ICU stay (2.0 [3.0] days versus 3.0 [8.0] versus 3.0 [9.5], p = 0.006), length of hospital stay (4.0 [4.5] days versus 6.0 [15.0] versus 10.5 [10.8], p < 0.001), and infection during hospitalization (19.8% versus 29.6% versus 63.6%, p < 0.001) but not in IHCA (7.6% versus 14.8% versus 11.4%, p = 0.323) or any adverse events (50.9% versus 48.1% versus 63.6%, p = 0.258). Multivariable analysis showed no significant association of triage BT with IHCA or any major complication.
CONCLUSION
Triage BT did not show a significant association with IHCA or adverse events in patients with acute MI. However, triage BT could be associated with different clinical presentations and should warrant further investigation.
Identifiants
pubmed: 37542240
doi: 10.1186/s12872-023-03372-y
pii: 10.1186/s12872-023-03372-y
pmc: PMC10403904
doi:
Substances chimiques
Troponin T
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
388Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Injury. 2014 Dec;45(12):1942-5
pubmed: 25458058
BMC Cardiovasc Disord. 2019 May 14;19(1):111
pubmed: 31088357
Biochem Med (Zagreb). 2021 Feb 15;31(1):010502
pubmed: 33380887
Lancet. 2001 Nov 10;358(9293):1571-5
pubmed: 11716882
J Crit Care. 2016 Apr;32:159-64
pubmed: 26922236
Eur J Clin Microbiol Infect Dis. 1999 Dec;18(12):852-8
pubmed: 10691195
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Sci Rep. 2021 Nov 9;11(1):21923
pubmed: 34754036
BMC Emerg Med. 2018 Dec 3;18(1):51
pubmed: 30509206
Int J Cardiol. 2014 Jan 1;170(3):376-80
pubmed: 24290071
Eur Heart J. 2020 Nov 7;41(42):4100-4102
pubmed: 33249465
Eur Heart J. 2019 Jan 14;40(3):237-269
pubmed: 30165617
Int J Environ Res Public Health. 2021 Nov 26;18(23):
pubmed: 34886188
Nat Rev Cardiol. 2014 May;11(5):255-65
pubmed: 24663091
Lancet. 1968 Dec 14;2(7581):1266-70
pubmed: 4177471
Am J Cardiol. 2009 Mar 15;103(6):779-84
pubmed: 19268731
Int J Cardiol. 1988 Jul;20(1):65-71
pubmed: 3042637
Am Heart J. 1978 Aug;96(2):153-6
pubmed: 676974
J Card Fail. 2007 Feb;13(1):25-33
pubmed: 17339000
Circulation. 2010 Jun 8;121(22):2437-45
pubmed: 20530020
Ther Hypothermia Temp Manag. 2021 Sep;11(3):135-144
pubmed: 32552523
Coron Artery Dis. 2002 May;13(3):177-81
pubmed: 12131022
Int J Environ Res Public Health. 2022 Jan 03;19(1):
pubmed: 35010760
Cardiol J. 2012;19(4):369-73
pubmed: 22825897
Crit Care. 2013 Nov 13;17(6):R271
pubmed: 24220071
Emerg Med J. 2016 Dec;33(12):843-847
pubmed: 27334759
J Immunol Res. 2020 Aug 18;2020:4904217
pubmed: 32908939
Resuscitation. 2017 Sep;118:35-42
pubmed: 28689048
J Am Coll Cardiol. 2001 Sep;38(3):736-41
pubmed: 11527626
Am J Emerg Med. 2020 Feb;38(2):203-210
pubmed: 30795946
Nature. 2012 Jul 19;487(7407):325-9
pubmed: 22763456
Am Heart J. 2006 Jun;151(6):1255.e1-5
pubmed: 16781231
Ann Transl Med. 2020 Nov;8(21):1371
pubmed: 33313116
BMC Emerg Med. 2022 Mar 27;22(1):53
pubmed: 35346055
Acute Med. 2019;18(3):141-143
pubmed: 31536050
Cardiovasc Endocrinol. 2016 Dec;5(4):151-154
pubmed: 28111609
Cardiology. 2005;103(4):169-73
pubmed: 15785024
Int J Cardiol. 2017 Jan 15;227:656-661
pubmed: 27810290
Clin Chem. 1987 Jun;33(6):1083-4
pubmed: 3594803
J Am Heart Assoc. 2017 Apr 24;6(4):
pubmed: 28438740
Int J Cardiol. 1990 Aug;28(2):269-72
pubmed: 2394532
J Crit Care. 2020 Dec;60:27-31
pubmed: 32731103
Int J Med Inform. 2021 Aug;152:104505
pubmed: 34030088
Clin Infect Dis. 2020 Jul 27;71(3):499-513
pubmed: 31504334
Circ J. 2016 May 25;80(6):1427-36
pubmed: 27118621